General MedicationsINHALATIONStandard

IPRATROPIUM BROMIDE

Standard Dose

0.021MG/INH

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 217953 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IPRATROPIUM BROMIDE Form and strength AEROSOL, METERED;INHALATION - 0.021MG/INH Sponsor ARMSTRONG PHARMS Submission history Latest submission status date: 2026-02-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview IPRATROPIUM BROMIDE is listed in Drugs@FDA under application 217953 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IPRATROPIUM BROMIDE Form and strength AEROSOL, METERED;INHALATION - 0.021MG/INH Sponsor ARMSTRONG PHARMS Submission history Latest submission status date: 2026-02-23 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.